@article {Lee48, author = {Kelvin H. Lee and Jennifer L. Mantle}, title = {Summary from Advanced Manufacturing Technology Workshop Held at 6th Accelerating Biopharmaceutical Development Meeting}, volume = {75}, number = {1}, pages = {48--63}, year = {2021}, doi = {10.5731/pdajpst.2020.011429}, publisher = {Parenteral Drug Association (PDA)}, abstract = {A workshop was held at the 6th Accelerating Biopharmaceutical Development meeting in Carlsbad, CA on February 18, 2019. An anonymous survey was sent to all industry participants before the meeting to identify their top technological barriers to achieving a future manufacturing state and a real-time polling tool was used to collect live feedback during the meeting. Senior leaders from across the biopharmaceutical industry discussed the top technology opportunities to enable high-throughput, flexible manufacturing capabilities and business drivers for the industry. New analytical technologies and upstream operations were identified to be opportunities that could have a profound effect on the shift toward flexible manufacturing. Further discussion at the workshop also identified key business drivers, such as speed, simplicity, and flexibility, as well as the global regulatory environment, to be factors that have a major impact on an organization{\textquoteright}s ability to implement flexible manufacturing. This workshop has identified industry-wide needs and concerns and can inform future industry-wide initiatives and prioritization of resources to achieve more flexible manufacturing.}, issn = {1079-7440}, URL = {https://journal.pda.org/content/75/1/48}, eprint = {https://journal.pda.org/content/75/1/48.full.pdf}, journal = {PDA Journal of Pharmaceutical Science and Technology} }